A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

Clinical trial NCT06970496 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06970496
Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory B Cell Non Hodgkin Lymphoma

Start date: 2026-08-31
Primary completion: 2026-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.